ReviewDiscover nano2026
Mechanistic advances in microbial nanobiotechnology and their applications in sustainable agriculture, environment and biomedicine.
Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Smart Mesoporous Silica Nanoparticle-Based Drug Delivery Systems: Recent Advances in Biomedical Applications, Wound Healing and Therapeutic Perspectives.Pharmaceutics · 2026Review
- Microbial Synthesis of Precious Metal Nanoparticles and Their Applications: A Review.Microorganisms · 2026Review
- Bioengineered Silver Nanoparticles: Next-Generation Biogenic Synthesis Strategies for Precision Biomedical Applications.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial nanobiotechnology represents a groundbreaking convergence of microbiology and nanotechnology offering sustainable and innovative solutions across diverse fields. This review explores the emerging trends in microbial nanobiotechnology with a focus on tools, applications, and challenges. Microorganisms including bacteria, fungi, and algae possess exceptional ability to biosynthesize nanoparticles through environmentally benign and cost-effective biochemical pathways. These biogenic nanoparticles, characterized by their controlled size, shape, and functional properties have demonstrated potential in biomedical applications, including targeted drug delivery, imaging, and antimicrobial treatments. Furthermore, microbial nanotechnology plays a pivotal role in environmental remediation contributing to wastewater treatment and pollution control as well as in industrial applications such as agriculture and energy production. The review highlights the integration of advanced tools like genetic engineering, synthetic biology, which have revolutionized nanoparticle synthesis and characterization. However, significant challenges remain including scalability, biosafety, regulatory concerns, and ethical implications. Addressing these barriers is crucial for advancing microbial nanobiotechnology from research to commercial applications. By providing a comprehensive overview, this review aims to serve as a resource for researchers and practitioners offering insights into the future directions and multidisciplinary collaborations necessary for the growth of field. Microbial nanobiotechnology stands poised to address global challenges in health, environment, and industry marking a new frontier in science and technology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.